Tuesday 1st November, 2016
12:30am to 2:00pm
Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. In addition, novel developments such as single cell analysis and gene editing present exciting new opportunities.
This meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease.
For sponsorship and exhibition oppertunities, please contact us.
Student rates from: GBP 374
Academic rates from: GBP 474
Industry rates from: GBP 574
Speakers: Edith Heard Institut Curie France, Doug Higgs University of Oxford UK, Caroline Relton University of Bristol UK, Art Petronis University of Toronto Canada
Sign in to add slides, notes or videos to this session